UPDATE: Citigroup Initiates Coverage On Atara Biotherapeutics On New Lead Product Candidates

By: via Benzinga
In a report published Monday, Citigroup analyst Yaron Werber initiated coverage on Atara Biotherapeutics Inc (NASDAQ: ATRA) with a Buy ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.